I

IHH Healthcare Bhd
OTC:IHHHF

Watchlist Manager
IHH Healthcare Bhd
OTC:IHHHF
Watchlist
Price: 1.71 USD Market Closed
Market Cap: $15.1B

Wall St Price Targets

IHHHF Price Targets Summary
IHH Healthcare Bhd

Wall Street analysts forecast IHHHF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IHHHF is 2.03 USD with a low forecast of 1.68 USD and a high forecast of 2.3 USD.

Lowest Forecast
Price Target
1.68 USD
2% Downside
Average Forecast
Price Target
2.03 USD
19% Upside
Highest Forecast
Price Target
2.3 USD
34% Upside
IHH Healthcare Bhd Competitors:
Price Targets
NTHI
NeOnc Technologies Holdings Inc
246% Upside

Revenue
Forecast

16% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 2 years is 15%.

Gross Profit
Forecast

16% / Year
Past Growth
-2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
-2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 2 years is -2%.

Operating Income
Forecast

16% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 2 years is 16%.

Pre-Tax Income
Forecast

15% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
15% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 2 years is 21%.

Net Income
Forecast

13% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 2 years is 19%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IHHHF's stock price target?
Price Target
2.03 USD

According to Wall Street analysts, the average 1-year price target for IHHHF is 2.03 USD with a low forecast of 1.68 USD and a high forecast of 2.3 USD.

What is the Revenue forecast for IHH Healthcare Bhd?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 2 years is 15%.

What is the Gross Profit forecast for IHH Healthcare Bhd?
Projected CAGR
-2%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 2 years is -2%.

What is the Operating Income forecast for IHH Healthcare Bhd?
Projected CAGR
16%

Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 2 years is 16%.

What is the Pre-Tax Income forecast for IHH Healthcare Bhd?
Projected CAGR
21%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 2 years is 21%.

What is the Net Income forecast for IHH Healthcare Bhd?
Projected CAGR
19%

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 2 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett